Long-term survival of patients with metastatic melanoma (MM) treated with dacarbazine (DTIC) or temozolomide (TMZ)

被引：0
|
作者：
Kim, C.
Lee, C. W.
Klasa, R.
Shah, A.
Savage, K. J.
机构：
[1] Univ British Columbia, Vancouver, BC V5Z 1M9, Canada
[2] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9054
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Durable responses and long-term progression-free survival observed in a phase II study of MOX-010 alone or in combination with dacarbazine (DTIC) in metastatic melanoma.
    Fischkoff, SA
    Hersh, E
    Weber, J
    Powderly, J
    Khan, K
    Pavlick, A
    Samlowski, W
    O'Day, S
    Nichol, G
    Yellin, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 716S - 716S
  • [22] CORRELATES OF OUTCOME IN PATIENTS WITH METASTATIC MELANOMA TREATED WITH DACARBAZINE
    Gao, B.
    Tiley, S. M.
    Gebski, V.
    Mann, G.
    Kefford, R.
    ANNALS OF ONCOLOGY, 2008, 19 : 246 - 246
  • [23] Predictors of long-term survival in stage IV malignant melanoma (MM) patients
    Bafaloukos, D
    Fountzilas, G
    Semoglou, C
    Vasilaki, V
    Kosmidis, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1166 - 1166
  • [24] Temozolomide and nivolumab in patients with refractory metastatic melanoma (MM)
    Quintos, Jessica
    Schellhammer, Sophie
    Ancell, Kristin Kathleen
    Johnson, Douglas Buckner
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Survival and long-term toxicities of biochemotherapy for metastatic melanoma
    Minor, D. R.
    Miller, J.
    Kashani-Sabet, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] Long-term Survival after Metastatic Childhood Melanoma
    Larsen, Anne Kristine
    Jensen, Mette Bybjerg
    Krag, Christen
    PLASTIC AND RECONSTRUCTIVE SURGERY-GLOBAL OPEN, 2014, 2 (06)
  • [27] Long-term survival in metastatic uveal melanoma (MUM)
    Neumann, Sophie Piperno
    Dureau, Sylvain
    Rodrigues, Manuel Jorge
    Desjardins, Laurence
    Pierron, Gaelle
    Levy-Gabriel, Christine
    Lumbroso, Livia
    Servois, Vincent
    Najean, Marie
    Savignoni, Alexia
    Cassoux, Nathalie
    Mariani, Pascale
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Takeshi Fukumoto
    Susumu Fujiwara
    Masanobu Sakaguchi
    Masahiro Oka
    Naomi Kiyota
    Yasuo Ejima
    Koichi Nakajima
    Chikako Nishigori
    European Journal of Dermatology, 2017, 27 : 177 - 178
  • [29] Long-term survival of a patient with metastatic melanoma treated with nivolumab and vemurafenib, with the development of vitiligo
    Fukumoto, Takeshi
    Fujiwara, Susumu
    Sakaguchi, Masanobu
    Oka, Masahiro
    Kiyota, Naomi
    Ejima, Yasuo
    Nakajima, Koichi
    Nishigori, Chikako
    EUROPEAN JOURNAL OF DERMATOLOGY, 2017, 27 (02) : 177 - 178
  • [30] Phase III, open-label, randomized, comparative study of tremelimumab (CP-675,206) and chemotherapy (temozolomide [TMZ] or dacarbazine [DTIC]) in patients with advanced melanoma
    Ribas, A.
    Hauschild, A.
    Kefford, R.
    Punt, C. J.
    Haanen, J. B.
    Marmol, M.
    Garbe, C.
    Gomez-Navarro, J.
    Pavlov, D.
    Marshall, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345